Safety and Effectiveness of Combining Hydroxyurea (HU) With Didanosine (ddI) and Stavudine (d4T) for Treatment of HIV-Infected Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

225

Participants

Timeline

Start Date

May 31, 1999

Conditions
HIV Infections
Interventions
DRUG

Hydroxyurea

DRUG

Stavudine

DRUG

Didanosine

Trial Locations (18)

10550

Mt Vernon Hosp, Mount Vernon

19104

Univ of Pennsylvania Med Ctr, Philadelphia

19107

Thomas Jefferson Univ, Philadelphia

20037

Dr Bruce Rashbaum, Washington D.C.

29464

Coastal Carolina Research Ctr, Mt. Pleasant

30308

AIDS Research Consortium of Atlanta Inc, Atlanta

32209

Boulevard Comprehensive Care Ctr, Jacksonville

32701

IDC Research Initiative, Altamonte Springs

33609

Center for Quality Care, Tampa

75235

Univ of Texas Southwestern Med Ctr of Dallas, Dallas

77006

Montrose Clinic, Houston

90027

AIDS Healthcare Foundation, Los Angeles

94121

San Francisco VA Med Ctr, San Francisco

98122

Swedish Med Ctr, Seattle

122083479

Albany Med College, Albany

775550835

Univ of Texas Med Branch, Galveston

06901

Gary Blick MD, Stamford

02111

New England Med Ctr, Boston

All Listed Sponsors
lead

Research Institute for Genetic and Human Therapy

OTHER

NCT00002427 - Safety and Effectiveness of Combining Hydroxyurea (HU) With Didanosine (ddI) and Stavudine (d4T) for Treatment of HIV-Infected Adults | Biotech Hunter | Biotech Hunter